Ftse Mib
33.959,66
-0,98%
DAX
18.014,81
-0,65%
S&P 500
5.116,17
0,00%
NASDAQ Composite
15.983,08
0,00%
Bitcoin
61.155,09
-4,20%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vertex Pharmaceuticals Inc (VRTX) Vertex Pharmaceuticals Inc (VRTX) Notizie

Vertex Pharmaceuticals Inc

VRTX
396,20
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 15:09:12
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/4/202417:43BWVertex Announces European Commission Approval for KALYDECO®..
23/4/202406:45PRNUSVERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING..
18/4/202414:00BWVertex Announces Advancements of Suzetrigine (VX-548) in..
11/4/202413:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
10/4/202422:01BWVertex Enters Into Agreement to Acquire Alpine Immune..
09/4/202422:05BWVertex to Announce First Quarter 2024 Financial Results on..
01/4/202417:00PRNCAVertex annonce que la présentation de drogue nouvelle..
01/4/202414:00BWVertex Advances Inaxaplin (VX-147) into Phase 3 Portion of..
21/3/202413:00BWVertex Announces FDA Clearance of Investigational New Drug..
27/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202419:19EDGAR2Form 144 - Report of proposed sale of securities
26/2/202417:25EDGAR2Form 144 - Report of proposed sale of securities
26/2/202417:10EDGAR2Form 144 - Report of proposed sale of securities
26/2/202416:52EDGAR2Form 144 - Report of proposed sale of securities
26/2/202416:44EDGAR2Form 144 - Report of proposed sale of securities
26/2/202416:26EDGAR2Form 144 - Report of proposed sale of securities
23/2/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202413:10BWVertex Receives CHMP Positive Opinion for KALYDECO® for the..
21/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202417:38EDGAR2Form 144 - Report of proposed sale of securities
21/2/202416:52EDGAR2Form 144 - Report of proposed sale of securities
21/2/202416:44EDGAR2Form 144 - Report of proposed sale of securities
21/2/202416:16EDGAR2Form 144 - Report of proposed sale of securities
21/2/202415:50EDGAR2Form 144 - Report of proposed sale of securities
21/2/202415:43EDGAR2Form 144 - Report of proposed sale of securities
20/2/202422:05BWVertex to Participate in Upcoming Investor Conferences
20/2/202417:29EDGAR2Form 144 - Report of proposed sale of securities
20/2/202417:03EDGAR2Form 144 - Report of proposed sale of securities
20/2/202416:57EDGAR2Form 144 - Report of proposed sale of securities
20/2/202416:32EDGAR2Form 144 - Report of proposed sale of securities
20/2/202416:22EDGAR2Form 144 - Report of proposed sale of securities
20/2/202416:22EDGAR2Form 144 - Report of proposed sale of securities
Apertura: Min: Max:
Chiusura: 396,20

La tua Cronologia

NASDAQ
VRTX
Vertex Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network